C
Clifton D. Fuller
Researcher at University of Texas MD Anderson Cancer Center
Publications - 470
Citations - 10137
Clifton D. Fuller is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 44, co-authored 397 publications receiving 7300 citations. Previous affiliations of Clifton D. Fuller include University of Texas System & University of Texas Health Science Center at San Antonio.
Papers
More filters
Journal ArticleDOI
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
D. A. Agbamu,N. Day,C. J. Walsh,C. W. Hendrickse,G. Langman,A. Pallan,A. Lowe,J. Ostrowski,M. Steward,M. Callaway,Stephen Falk,Michael Thomas,N. Wong,J. Hartley,A. W. MacDonald,D. Blunt,P. Cohen,P. Dawson,Charles Lowdell,D. Furniss,R. Gupta,R. D. Taraporewalla,Michael Braun,N. Cruickshank,S. Muzaffar,David J. Smith,F. Daniel,J. Denson,Stephen H D Jackson,K. Sleigh,E. Kweka,H. J. Pearson,M. Peters,Rajarshi Roy,G. Kurien,J. Robinson,Jonathan Wadsley,D. White,M. J. Lamparelli,J. Mikel,R. Osborne,P. Taylor,I. C. Ilesley,Brendan J. Moran,H. O'Neill,Charlotte Rees,A. Buxton,J. Harrison,D. Scullion,J. Hyde,D. Ilsley,U. Raja,Corran Roberts,M. Crabtree,J. Orrell,Sarah Smith,Rubin Soomal,James Hill,G. Howarth,S. Lee,R. Church,A. Hartley,C. Holland,A. K. Thompson,Rob Glynne-Jones,J. Livingstone,P. Richman,M. Train,C. Barlow,P. Burn,J. Geraghty,C. J. Vickery,J. Walther,Simon Aird Grumett,S. A.M. Mangalika,M. Qaiyum,Geraint T. Williams,R. Borgstein,John Bridgewater,L. Meleagros,J. A. Rees,S. J. Needham,Jacob G. Scott,A. Anathhanam,J. Brittenden,C. Macklin,Daniel Swinson,J. Alexander,Tamas Hickish,R. W. Talbot,D. Tarver,O. Lalude,W. Partridge,V. Sundaresan,D. Cowlishaw,A. Higginson,S. R. Muthuramalingam,D. P. O'Leary,B. T. Ismail,Dion Morton,A. Page,N. Steven,Phillipe Taniere,J. Gutmann,J. Huang,Sherif Raouf,I. T. Saeed,W. K. Dunn,Vanessa Potter,J. H. Scholefield,A. Zaitoun,D. Eason,G. Stenhouse,K. G. Walker,A. J. Watson,D. Whillis,B. Fozard,J. McCutcheon,S. Snape,Richard J. Ellis,W. Faux,G. Maskell,J. Mathew,J. R.G. Bell,A Mayer,O. A. Ogunbiyi,J. Watkins,C. Bronder,D. Eaton,N. Mapstone,Angela E Taylor,Gina Brown,David Cunningham,Paris P. Tekkis,A C Wotherspoon,D. Barber,M. Dobson,M. Pitt,N. Scot,S. Susnerwala,David Ferry,Andrew J. Hall,A. Kawesha,A. Sherif,Graham Branagan,S. Cook,Clifton D. Fuller,T. Iveson,R. Donovan,D. Peake,S. M. Ahmad,A. Coup,A. Hamid,D. Pai,A. C. Bateman,Andrew Bateman,R. M. Blaquiere,P. Nichols,M. J. Dworkin,S. Jain,A. Malhotra,B. Pravee,D. Tsang,K. Hopkins,E. Loveday,Anne Pullyblank,N. Rooney,A. Chiphang,S. Dundas,A. S. Myint,M. Zeiderman,N. Beharry,Caroline Finlayson,R. Hagger,F. Lofts,D. M. Melville,Paul J. Finan,Nigel Scott,Matthew T. Seymour,D. Tolan,Jurjees Hasan,V. Howarth,Samir Mehta,M. Saeed,Fiona Campbell,M. L. Hughes,P. Rooney,F. Adab,I. Britton,Carolyn S. Hall,C. Phelan,A. Moss,N. Pranesh,D. Shareef,J. Whalley,Rizvana Ahmad,Sujal R. Desai,S. Ramesh,C. Ramsey,S. Amin,J. Hampton,Joanne Hornbuckle,P. Kitsanta,A. L. Desai,Marcia Hall,M. Thyveetil,A. Baxter,David Farrugia,S. P. Lake,Tracy E Roberts,G. T. Smith,M. Charig,T. Burdge,P. Chandran,C. Corr,Simon Gollins,S. Pritchard,M. Scott,S. Sukumar,A. Clarke,J. Haselden,N. Woodcock,A. Maw,C. Bale,E. Favill,M. Clwyd,W. Atkinson,M. Gupta,H. Burnett,S. Hayes,N. Lees +230 more
TL;DR: The FOxTROT trial aims to investigate the feasibility, safety, and efficacy of preoperative chemotherapy for colon cancer, and to establish whether the encouraging pathological responses seen with preoperative therapy translates into improved long-term oncological outcome.
Journal ArticleDOI
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy
Aaron J. Grossberg,Aaron J. Grossberg,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,Hesham Elhalawani,William C. Bennett,Kirk E. Smith,Tracy S. Nolan,Bowman Williams,Sasikarn Chamchod,J. Heukelom,J. Heukelom,Michael E. Kantor,Theodora Browne,Katherine A. Hutcheson,G. Brandon Gunn,Adam S. Garden,William H. Morrison,Steven J. Frank,David I. Rosenthal,John Freymann,Clifton D. Fuller +21 more
TL;DR: In the original version of the Data Descriptor the surname of author Hesham Elhalawani was misspelled and this has now been corrected in the HTML and PDF versions.
Journal ArticleDOI
Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
Aaron J. Grossberg,Sasikarn Chamchod,Clifton D. Fuller,Abdallah S.R. Mohamed,Abdallah S.R. Mohamed,J. Heukelom,Hillary Eichelberger,Michael E. Kantor,Katherine A. Hutcheson,G. Brandon Gunn,Adam S. Garden,Steven J. Frank,Jack Phan,Beth M. Beadle,Heath D. Skinner,William H. Morrison,David I. Rosenthal +16 more
TL;DR: Diminished SM mass assessed by CT imaging or BMI can predict oncologic outcomes for patients with HNSCC, whereas weight loss after RT initiation does not predict SM loss or survival.
Journal ArticleDOI
Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?
Reid F. Thompson,Gilmer Valdes,Clifton D. Fuller,Colin M. Carpenter,Olivier Morin,Sanjay Aneja,William D. Lindsay,Hugo J.W.L. Aerts,Barbara Agrimson,Curtiland Deville,Seth A. Rosenthal,James B. Yu,Charles R. Thomas +12 more
TL;DR: The current state and anticipated future impact of AI on Radiation Oncology is explored, in detail, focusing on key topics from multiple stakeholder perspectives, as well as the role the specialty may play in helping to shape the future of AI within the larger spectrum of medicine.
Journal ArticleDOI
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer.
David I. Rosenthal,Mark S. Chambers,Clifton D. Fuller,Neal Rebueno,John Garcia,Merrill S. Kies,William H. Morrison,K. Kian Ang,Adam S. Garden +8 more
TL;DR: Dose reduction to specified structures during IMRT implies an increased beam path dose to alternate nontarget structures that may result in clinical toxicities that were uncommon with previous, less conformal approaches.